Login

Dror Bashan, CEO, Protalix Biotherapeutics Inc 00:00:00

Share On Facebook Share On Twitter

Protalix BioTherapeutics looks to commercialize its Fabry Disease therapy

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Buy vs. Lease: Do You Really Need a Car Payment? | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:10:00
early-stage investments in technology sector give a huge profit in near future|George Zachary,General Partner,CRV
00:10:00
"Navigating Economic Uncertainty: Insights from JNBA's Investment Committee" | Richard S. Brown - CHAIRMAN & CHIEF EXECUTIVE OFFICER of JNBA Financial Advisors
00:10:00
Rachel Stephanie, Director of PT M Cash Integrasi Tbk (MCAS), announced that the company has budgeted capital expenditures for the year.
00:10:00
Lumina Group Showcases Ecuadorian Gold Projects at One-to-One Conference
00:10:00
Focuses on investments across consumer-facing landscapes|Assia Grazioli,Co-founder and Partner,Muse Capital
00:10:00
Axiom Group Introduces NRG Xcite System for Exploration at PDAC
00:10:00
Discovering New Perspectives in ETFs and Financial Innovation | Jenny Johnsons, Chief Executive Officer , Franklin Templeton .
00:10:00
Commodity Market Trends and Projections
00:10:00
Rodolfo de Benedetti former CEO of CIR Group (Compagnie Industriali Riunite) | Monica Mondardini, CEO, CIR SpA - Compagnie Industriali RiuniteCIR:MIL
00:10:00
Vista Gold: Advancing the Mount Todd Gold Project in Australia's Northern Territory
00:10:00
Early-stage venture firm designed to back lateral thinkers|Brandon Farwell,General Partner,Xfund

© 2017 - Neuhu+